NASDAQ:ADVB
Advanced Biomed Inc.
Advanced Biomed Inc. reported net income of −$3.3M in fiscal 2025. Free cash flow was −$5.9M, and the diluted share count rose 2.6%.Summary generated from Advanced Biomed Inc.'s SEC filings. Latest annual report filed Oct 8, 2025.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)n/a
Revenue growthn/a
Revenue, 5-yr CAGRn/a
Gross marginn/a
Operating marginn/a
Net marginn/a
ROICn/a
Return on equity−126.8%
Debt / equityn/a
Free cash flow−$5.9M
FCF marginn/a
Share count change+2.6%
Financials
| Item | 2024 | 2025 |
|---|---|---|
| Revenue | n/a | n/a |
| Operating income | n/a | n/a |
| Net income | −3 | −3 |
| Free cash flow | −2 | −6 |
Recent filings
- 4Insider transaction report
Aug 20, 2026 - 8-KTermination of a material agreement
Jul 17, 2026 - 8-KResults of a shareholder vote
Jul 1, 2026 - 8-KEntry into a material agreement
Jun 30, 2026 - DEF 14AProxy statement
Jun 4, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 15, 2026 - 8-KCompletion of an acquisition or disposition
May 1, 2026 - 8-KEntry into a material agreement
Apr 14, 2026